P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
about
Inhibition of Tat activity by the HEXIM1 proteinHIV-1 gene expression: lessons from provirus and non-integrated DNATat-SF1 protein associates with RAP30 and human SPT5 proteinsEvidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitroStructure and function of the human transcription elongation factor DSIFHuman transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complexCyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent mannerTRIM5α and Species Tropism of HIV/SIVThe histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcriptionAcetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcriptionA cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionIdentification of multiple cyclin subunits of human P-TEFbThe human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcriptionDSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologsPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesTranscriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomainEvidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequencesPhosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongationCDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNARelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterDomains in the SPT5 protein that modulate its transcriptional regulatory propertieshnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongationTranscriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent mannerCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionThe HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factorTIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcriptionCrystal structure of HIV-1 Tat complexed with human P-TEFbLARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associatedAn essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiaeProtein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase IIMAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent mannerA 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformationUnderstanding HIV latency: the road to an HIV curePhysical interaction between pRb and cdk9/cyclinT2 complexActivation of MyoD-dependent transcription by cdk9/cyclin T2Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionTat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes
P2860
Q21245206-36F7AD02-2977-4638-8BAC-DE3600C5DF8CQ21245215-F28A45C6-B6BE-4F42-880C-2029B496B636Q22003803-77F1D9B4-EFFC-4F0F-9F3C-FC6888161EB8Q22008559-A632C990-1777-4D39-8992-B3E481DB2046Q22009021-506454EE-78FD-4FCE-BD0C-AFD34BCA197DQ24296462-A0024125-0A80-4AD9-BD49-5B19622C3533Q24301811-10DEBD7B-1A4B-4FC7-B42E-BCE419680E27Q24304062-5A182605-19CF-446E-9082-DED19F86D3F6Q24307870-68F2CA23-EB3D-465F-A5A8-30E403EAF29AQ24310643-31EC6799-9972-491D-92E6-C87818F35A12Q24314052-D30D0560-8BB4-4E8C-8692-195492AF21F3Q24317025-08EFE35C-A83C-4138-AC89-558910EA93B2Q24318776-7BA51397-03A6-4AC2-86EB-ED7EFCE3042BQ24328838-D2FE14E6-32C1-4075-98C7-A8B83233C6E5Q24523183-717897DE-32C7-4734-AECC-E845C2F1F96AQ24533266-B08D03CF-F7B2-475A-B9AC-CC67B2B61DD8Q24534907-2D1AF3C0-B786-41EE-B83C-02229D6E4C43Q24537283-045F4991-F0E4-4931-A7A4-91B1E16199EEQ24537527-9933B81D-249E-45CA-A65E-DA535D59085BQ24537588-078EF230-2122-4945-B5CA-C48B1C07C921Q24550765-83D508B8-3A81-4621-BCA6-3DB6EE9BF4E0Q24552532-D5DE932D-891B-4434-B2F4-027C68135F68Q24554258-A784624F-62A1-4911-B00A-C3DB46BAD0BAQ24554421-A7C077AB-DAB8-4130-84B6-CC776BBF452BQ24554483-A453E1F1-18D0-4525-B070-5A3C9501D8DEQ24559797-99A518A1-C175-4DD5-8D41-0B632E1B15B2Q24596637-5AC37B7E-A255-4E8E-9B05-ADDB591DDBABQ24600874-07DCAF95-E32E-4F6F-87D3-A87A01D5F623Q24634280-EF1BC0D0-4E64-48FA-B3ED-FB8EF355C344Q24634569-D2440044-7BC4-46CE-95AF-133E51716C78Q24646322-E463E6BF-1962-4F34-8E5C-38043FF3DE20Q24649275-CDAFD0E2-713A-4611-BAE3-1A9A0B67924FQ24672654-DD3F5FE4-146B-4C73-AB93-651CC7353F1AQ24679741-66B8C78D-63C7-4808-9858-40C12D397ED9Q27765139-4919F596-FE82-4155-ACD8-905C4EF5F0DCQ28085296-8893294E-222A-4A8F-963E-4AB491617901Q28114798-2E6BFE9E-DF8C-440A-ADD6-0A5D703CB6F1Q28115623-D7914EA6-D71B-40FA-83C0-5A51A7A4E597Q28116305-6A88F570-AB6F-4F51-8747-0A2A40FCD56DQ28138220-414D6553-D672-4287-88C3-DED310818058
P2860
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@ast
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@en
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@nl
type
label
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@ast
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@en
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@nl
prefLabel
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@ast
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@en
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@nl
P2093
P2860
P3181
P356
P1433
P1476
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
@en
P2093
H S Mancebo
J Tomassini
P2860
P304
P3181
P356
10.1101/GAD.11.20.2633
P407
P577
1997-10-01T00:00:00Z